Considering the crucial and various physiological functions of APP, PS1 and tau in the central nervous system, it begs the question whether the biochemical and functional defects observed in AD transgenic mice are due to the pathological lesions or because of mutant protein overexpression [3]. The gene discussed is MAPT; the disease is Alzheimer disease.